Alpha Cognition Leadership Change
Alpha Cognition Inc. appointed Caren Deardorf to its Board of Directors, effective November 11, 2026. Ms. Deardorf, a biotechnology executive with over 30 years of experience, will serve on the Audit and Governance and Nomination Committees. As part of her appointment, she received an initial grant of 755 restricted stock units and 1,020 stock options with an exercise price of $8.62 per share.